Compare CVS Health Corp (CVS) vs SoundHound AI Inc (SOUN) Price & Performance

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

SoundHound AI (SOUN) trades at $6.49, down 2.26% on the day and 37% year-to-date, reflecting investor concerns over persistent losses despite strong revenue growth. The stock shows a bearish technical trend with neutral oscillators, while fundamentals reveal a high P/S of 15.03 and negative net income margin of -91.84%. Recent positive developments include being named a Leader in Gartner's Magic Quadrant for Conversational AI Platforms (GlobeNewsWire, July 13, 2026) and beating EPS estimates in three consecutive quarters.

The outlook remains high-risk with significant cash burn and execution challenges, but analyst consensus is bullish with a $13 price target (75% buy ratings). Investment opportunity hinges on successful integration of acquisitions like LivePerson and expansion into telecom/energy markets, though volatility from short interest and profitability concerns pose substantial downside risk.